Dianne Nicol

Summary

Affiliation: University of Tasmania
Country: Australia

Publications

  1. pmc Using TRIPS flexibilities to facilitate access to medicines
    Dianne Nicol
    University of Tasmania, Faculty of Law, Private Bag 89, Hobart, Tasmania 7001, Australia
    Bull World Health Organ 91:533-9. 2013
  2. doi Do patents impede the provision of genetic tests in Australia?
    Dianne Nicol
    Law Faculty, University of Tasmania, Hobart, Australia
    Aust Health Rev 37:281-5. 2013
  3. ncbi Balancing innovation and access to healthcare through the patent system--an Australian perspective
    Dianne Nicol
    Centre for Law and Genetics, Law Faculty, University of Tasmania, Hobart, TAS, Australia
    Community Genet 8:228-34. 2005
  4. ncbi Balancing access to pharmaceuticals with patent rights
    Dianne Nicol
    Law School, University of Tasmania, Australia
    Monash Bioeth Rev 22:50-62. 2003
  5. doi Benefit sharing and biobanking in Australia
    Dianne Nicol
    University of Tasmania, Australia
    Public Underst Sci 21:534-55. 2012
  6. ncbi Personalised medicine in the genome era
    Don Chalmers
    Centre for Law and Genetics, University of Tasmania, Private Bag 89, Hobart, TAS 7001, Australia
    J Law Med 20:577-94. 2013
  7. ncbi Human genetic research databases and biobanks: towards uniform terminology and Australian best practice
    Don Chalmers
    University of Tasmania, Australia
    J Law Med 15:538-55. 2008
  8. ncbi Gene patents--more evidence needed, but policymakers must act
    E Richard Gold
    Nat Biotechnol 25:388-9. 2007
  9. ncbi Trust, patents and public perceptions: the governance of controversial biotechnology research
    Timothy Caulfield
    Health Law Institute, University of Alberta, Canada
    Nat Biotechnol 24:1352-4. 2006
  10. ncbi Human gene patents: under whose control?
    Dianne Nicol
    Med J Aust 179:181-2. 2003

Detail Information

Publications10

  1. pmc Using TRIPS flexibilities to facilitate access to medicines
    Dianne Nicol
    University of Tasmania, Faculty of Law, Private Bag 89, Hobart, Tasmania 7001, Australia
    Bull World Health Organ 91:533-9. 2013
    ..Draft legislation currently being considered in Australia is used to illustrate how workable legislative frameworks can be developed. ..
  2. doi Do patents impede the provision of genetic tests in Australia?
    Dianne Nicol
    Law Faculty, University of Tasmania, Hobart, Australia
    Aust Health Rev 37:281-5. 2013
    ....
  3. ncbi Balancing innovation and access to healthcare through the patent system--an Australian perspective
    Dianne Nicol
    Centre for Law and Genetics, Law Faculty, University of Tasmania, Hobart, TAS, Australia
    Community Genet 8:228-34. 2005
    ....
  4. ncbi Balancing access to pharmaceuticals with patent rights
    Dianne Nicol
    Law School, University of Tasmania, Australia
    Monash Bioeth Rev 22:50-62. 2003
    ..This article discusses the extensive international negotiations occurring during the last couple of years that seek to provide an appropriate balance between access rights and patent rights...
  5. doi Benefit sharing and biobanking in Australia
    Dianne Nicol
    University of Tasmania, Australia
    Public Underst Sci 21:534-55. 2012
    ..The third is not clearly linked with any one norm of sharing behaviour. The implications of these findings on biobank benefit sharing arrangements are discussed. ..
  6. ncbi Personalised medicine in the genome era
    Don Chalmers
    Centre for Law and Genetics, University of Tasmania, Private Bag 89, Hobart, TAS 7001, Australia
    J Law Med 20:577-94. 2013
    ..The authors identify a number of ethical concerns that need to be addressed if the promise of personalised medicine is to be fully realised...
  7. ncbi Human genetic research databases and biobanks: towards uniform terminology and Australian best practice
    Don Chalmers
    University of Tasmania, Australia
    J Law Med 15:538-55. 2008
    ..This article reviews these international best practices with the aim of providing guidance for the development of appropriate regulatory structures in Australia...
  8. ncbi Gene patents--more evidence needed, but policymakers must act
    E Richard Gold
    Nat Biotechnol 25:388-9. 2007
  9. ncbi Trust, patents and public perceptions: the governance of controversial biotechnology research
    Timothy Caulfield
    Health Law Institute, University of Alberta, Canada
    Nat Biotechnol 24:1352-4. 2006
    ..The sustainability of many research endeavors, particularly in controversial areas, requires an understanding of public concerns. As such, governance strategies should be developed to sustain public trust...
  10. ncbi Human gene patents: under whose control?
    Dianne Nicol
    Med J Aust 179:181-2. 2003